Sarita Rastogi, MD
Geriatric Medicine · Hackensack, NJNPI 1073501094
Payments from drug & device makers
Across 392 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$770
- Boston Scientific$691
- Amgen$629
- Boehringer Ingelheim$625
- Pfizer$419
- plus $3K from 33 others
What the payments were for
- Food & beverage$6,99799%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 83 | $1,216 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 57 | $770 |
| Boston Scientific | 8 | $691 |
| Amgen | 23 | $629 |
| Boehringer Ingelheim | 20 | $625 |
| Pfizer | 31 | $419 |
| AstraZeneca | 14 | $319 |
| Lilly USA, LLC | 19 | $294 |
| GSK | 18 | $240 |
| Johnson & Johnson | 11 | $237 |
| Amarin Pharma, Inc. | 16 | $223 |
| Astellas Pharma US Inc | 9 | $172 |
| AbbVie(2 entities) | 12 | $168 |
| Bayer | 8 | $139 |
| QOL Medical, LLC | 14 | $132 |
| Biosense Webster, Inc. | 1 | $118 |
| Daiichi Sankyo Inc. | 6 | $83 |
| Vanda Pharmaceuticals Inc. | 6 | $78 |
| Exact Sciences | 4 | $68 |
| Almatica Pharma LLC | 4 | $55 |
| Biogen | 3 | $41 |
| Abbott | 2 | $40 |
| Medtronic | 2 | $38 |
| Vifor Pharma, Inc. | 2 | $31 |
| Insmed, Inc. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Althera Pharmaceuticals LLC | 2 | $24 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Cequr Corporation | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$371
- Watchman$250
- RESONATE EL ICD VR$142
- WATCHMAN FLX$135
- FARXIGA$125
- Repatha$125
- EVENITY$119
- Carto 3 System$118
- Ozempic$109
- Prolia$100
- TRULANCE$100
How this compares
$7,095 in reported general payments places this provider in the 90th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 171 | $156,977 |
| JardianceEmpagliflozin | 68 | $94,475 |
| OzempicSemaglutide | 63 | $83,105 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $25,921 |
| MyrbetriqMirabegron | 27 | $24,030 |
| JanuviaSitagliptin Phosphate | 12 | $16,292 |
| XareltoRivaroxaban | 16 | $14,881 |
| Rosuvastatin Calcium | 680 | $11,585 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,116 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $10,742 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $8,191 |
| Amlodipine Besylate | 797 | $7,474 |
| Losartan Potassium | 535 | $6,644 |
| Levothyroxine Sodium | 531 | $5,294 |
| Atorvastatin Calcium | 592 | $5,281 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $419 | $156,977171 claims |
| Boehringer IngelheimJardiance | $625 | $94,47568 claims |
| Novo NordiskOzempic | $1,216 | $83,10563 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $240 | $37,03744 claims |
| Astellas Pharma US IncMyrbetriq | $172 | $24,03027 claims |
| Johnson & JohnsonXarelto | $237 | $14,88116 claims |
| AbbVieSynthroid | $168 | $2,18028 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $14 | $1,80617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Hackensack
- Kalpana CheetiHackensack$2K
- Stefanos PantagisHackensack$2K
- Isao IwataPlainsboro$783K
- Albert RiddleHaworth$524K
- Joshua Shua HaimManchester$192K
- Gamil MakarClifton$82K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.